RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence
Haynes, B.
biochimica et biophysica acta - molecular basis of disease2020Vol. 1866pp. 0-0